Poland · Advertising framework
Podcast advertising and host-read promotions for diagnostic tests and services in Poland
General market orientation, not campaign clearance. Research scope and dates
Key restrictions and conditions
Healthcare activity: factual information must not become advertising
Legal requirement — paraphrased
Applies when: The message concerns healthcare activity; this is conditional for diagnostics, digital health, aesthetic procedures and wellness.
Where the offer is healthcare activity, Article 14 requires public information about the scope and types of services, while prohibiting advertising characteristics in its content and form. This applies to registered providers and professional practices; payment for a placement does not remove the restriction.
Editorial approach: start with identity, actual qualifications, service scope, location, access and neutral practical information. Have persuasive slogans, superiority claims, discounts and urgency devices assessed against the statutory restriction; do not present them as routinely permitted.
Sources: Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156 · Article 14
Product and service rules
Professional-use devices cannot be publicly advertised
Legal requirement — paraphrased
Applies when: The advertised offer is a regulated device or IVD.
For a regulated device/IVD, public advertising cannot concern a device intended for users other than laypersons. Public creative cannot use healthcare professionals, people posing as them, or presentations suggesting that profession; nor directly urge children to buy or persuade adults to buy.
Sources: Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Article 55
Keep device claims within the assessed intended purpose
Legal requirement — paraphrased
Applies when: The advertised offer is a regulated device or IVD.
If this is a device/IVD, do not invent functions, diagnostic performance or safety; imply unassessed uses; or obscure likely risks. Do not mislead about servicing or software updates. Explain claims in language a layperson can understand.
Sources: URPL — Advertising medical devices; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · MDR/IVDR Article 7 as explained by URPL; Device Act Articles 54–55
Device-based services can trigger a second advertising regime
Legal requirement — paraphrased
Applies when: The message advertises a device-based service within Article 58; assess the exact creative.
Device-advertising rules extend to business/professional services to the extent they concern services provided using a device, including rental. They also cover remunerated user opinions. A clinic's own account and a paid creator are not exempt.
Before showing equipment or device-based treatment benefits publicly, assess the lay-user restriction and healthcare-professional presentation restriction. For qualifying public advertising, check the identity, warning and format requirements in the device advertising regulation. Ordinary service information is not automatically device advertising.
Sources: Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620; Medical-device advertising regulation — Dz.U. 2023 item 817 · Device Act Article 58(1); advertising regulation sections 2–4
Obtain written approval and keep device-advertising records
Legal requirement — paraphrased
Applies when: The advertised offer is a regulated device or IVD.
For a regulated device/IVD, an advertiser other than the relevant economic operator needs that operator's written approval. Keep public-advertising specimens and placement information for two years after the end of the calendar year of dissemination; media providers/publishers have a separate minimum one-year retention duty.
Sources: URPL — Advertising medical devices · Device Act Articles 56 and 61, explained by URPL
Include device identity and the correct Polish warning
Legal requirement — paraphrased
Applies when: The exact message is public device advertising, including qualifying device-based service advertising under Article 58.
Apply this module only to qualifying public device advertising, including a device-based service falling within Article 58. It does not make an otherwise prohibited advertisement permissible.
For public device/IVD advertising, identify the advertiser, manufacturer and appointed authorised representative, alongside device name and intended purpose. The warning is: To jest wyrób medyczny. Używaj go zgodnie z instrukcją używania lub etykietą.
For Annex XVI non-medical-purpose products and device accessories, the regulation instead specifies: Dla bezpieczeństwa używaj zgodnie z instrukcją używania lub etykietą. Determine the correct branch before drafting.
Sources: Medical-device advertising regulation — Dz.U. 2023 item 817; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Sections 1–3
Fit device warnings to image, audio or video
Legal requirement — paraphrased
Applies when: The exact message is public device advertising, including qualifying device-based service advertising under Article 58.
Apply this module only to qualifying public device advertising, including a device-based service falling within Article 58. It does not make an otherwise prohibited advertisement permissible.
Audiovisual: warning in the bottom 15% or more, clearly spoken in Polish for at least four seconds. Audio: at least four seconds of clear Polish warning. Visual: bottom 10% or more, on the first page of multipage advertising. Observe the prescribed contrast, static horizontal text and spacing.
Sources: Medical-device advertising regulation — Dz.U. 2023 item 817; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Section 3(3)
Separate test-kit promotion from laboratory services
Editorial overview
An IVD kit, a laboratory examination and a test-interpretation service can trigger different rules. Professional laboratory equipment is not a consumer self-test merely because a sample is collected at home. If a provider promotes diagnostic services, the healthcare-information restriction also applies.
As an editorial check, describe sample type, intended user, limitations and the meaning of positive/negative results accurately. Avoid suggesting that one screening result rules out every disease or replaces clinically indicated follow-up.
Sources: Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620; Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156 · Device Act Article 55; Healthcare Activity Act Article 14
Protect patients before using stories, images or testimonials
Editorial overview
Applies when: Patient information or identifiable treatment material is used.
Do not assume treatment consent authorises a public case study, testimonial or before/after photograph. Check confidentiality, privacy and a separate lawful basis for the proposed disclosure, including health data; public responses to reviews must not reveal confidential treatment details.
Editorial safeguard: obtain a specific, voluntary publication permission for the intended material and channels, assess identifiability even when the face is hidden, and check that refusing publicity does not affect care. Publication permission cannot cure unlawful advertising or misleading outcome claims.
Sources: Patient Rights Act — consolidated text, Dz.U. 2024 item 581; Regulation (EU) 2016/679 — General Data Protection Regulation · Patient Rights Act Articles 13–14 and 20; GDPR Articles 5–7 and 9
Identify the operator responsible for advertising approval
Regulator guidance
Applies when: The offer is a regulated device or IVD.
Written approval for an outside advertiser does not transfer the economic operator’s statutory responsibility to the agency or creator. Keep approval and publication records attached to the exact version of the advertisement.
The economic operator’s two-year period runs from the end of the calendar year of dissemination. The separate media-provider/publisher minimum is one year; these are different duties.
Sources: URPL — Advertising medical devices · URPL overview: written approval, responsibility and retention; Act Articles 56 and 61
Channel rules
Make the overall message truthful and commercially identifiable
Legal requirement — paraphrased
Misleading claims, material omissions, hidden commercial intent and aggressive consumer marketing are prohibited. Assess visuals, comparisons, qualifications and the impression on vulnerable consumers. Do not falsely claim that a product cures illness.
Editorial control: retain substantiation before publication, remove fabricated urgency or authority badges, and check that qualifications do not contradict the headline. Paying to publish apparently independent advice must not conceal its commercial nature.
Sources: Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Articles 4–9; Article 7 hidden advertising and false cure claims
Check price reductions only after establishing that promotion is lawful
Legal requirement — paraphrased
Where an advertisement announces a reduction for a good or service, state the relevant lowest price from the preceding 30 days alongside the reduced price. For a shorter selling history, use the lowest price since sales began; special rules apply to rapidly perishable goods.
This consumer-information rule does not permit a discount or purchasing incentive prohibited by medicine or service rules. As an editorial check, make the total scope and extra charges clear.
Sources: UOKiK — Information about price reductions · Price Information Act Article 4 as explained by UOKiK
Keep reviews genuine and explain verification
Legal requirement — paraphrased
Do not publish, commission or distort false consumer recommendations. If making consumer reviews available, explain whether and how their origin is verified. Do not claim authentic-user verification without reasonable, proportionate checks.
Selecting a patient or customer story for advertising also requires checking the sector's claims and endorsement restrictions. A genuine testimonial can still contain an unlawful health claim.
Sources: UOKiK — False reviews? Stop!; Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Unfair-practices Act Articles 6–7; UOKiK reviews guidance
Make host-read advertisements recognisable in audio
Editorial recommendation
Recommended implementation: identify the commercial segment audibly when it begins and identify the advertiser; do not rely solely on show notes to reveal sponsorship. Apply category restrictions to host experience, expert interviews and affiliate recommendations.
Where medicine or device audio advertising is lawful, include its required spoken information and warning. Do not accelerate the warning so it becomes unclear. A video podcast needs a separate audiovisual assessment.
Sources: Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845; Medicine advertising regulation — consolidated text, Dz.U. 2023 item 1648; Medical-device advertising regulation — Dz.U. 2023 item 817 · Hidden-commercial-intent rules and audio advertising formats
Campaign workflow
Keep one campaign evidence and approval record
Editorial recommendation
Recommended workflow: record the exact offer and legal classification, advertiser, selected channel and creative formats; list permitted claims and evidence; review the Polish execution and destination; record sign-off, publication and corrections.
Keep the source date with the rule. Recheck legislation flagged as changing, especially pharmacy advertising. Preserve statutory archive periods where they apply; this suggested general workflow does not create a universal retention period.
Sources: URPL — Advertising medical devices; Sejm official API — Pharmacy advertising amendment, process 3002 · Specific retention and legislative-watch sources; workflow is editorial
Pre-publication checklist
- Confirm the provider's legal status and keep public service information factual in content and form.
- Document whether Article 58 applies and whether a professional-use device makes the proposed public promotion impermissible.
- Record the category gate before reviewing the channel.
- Approve the final creative, disclosure, targeting and landing page together.
- Assign an owner for corrections, expiry of claims and legislative updates.
Scope and unresolved questions
- Product authorisations, intended users, approved documentation and final Polish creative must be checked for the actual offer. Veterinary products, controlled substances, vaccine exceptions and specialist product subtypes are not separately cleared by this category-level guide.
- Check the chosen platform/provider's current health-advertising, tracking and targeting policies for the actual account and country. This source pack covers legal/regulator rules, not every vendor policy.
- Confirm the service's legal classification, broadcaster jurisdiction and booking format. Cross-border broadcasts, on-demand services, sponsorship and product placement can need additional analysis.
Research scope, introduction and dates
For diagnostic tests and services in podcasts and digital audio in Poland, establish what is actually being offered: a test kit, laboratory examination or interpretation service. That classification determines which device and healthcare-information rules need to be read together.
Podcast listeners may hear a promotion without seeing its show notes. Assess audible commercial identification, the host's statements and required spoken information in the recording itself; a filmed podcast also needs a visual-format review.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
Resolve product and service restrictions before choosing a channel
Editorial overview
A platform label, newsletter consent, an advertising warning or a publisher's acceptance does not create permission to advertise. Apply the selected product/service gate first; if public promotion is prohibited, use this guide to identify the restriction and alternatives for specialist review.
This English guide describes Polish requirements. Required Polish warning text and locally understandable disclosure remain necessary where the law requires them.
Sources: Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612; Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Product/service rules referenced in matching modules
Confirm whether the offer is a medical device or IVD
Editorial overview
For diagnostics and digital health, first establish whether this is a regulated device, an IVD, a healthcare service or a general wellness product. The following device rules apply only where the advertised product qualifies as a device/IVD. A CE mark is not regulatory approval of advertising claims.
Sources: Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620; URPL — Advertising medical devices; MDCG 2019-11 rev.1 — Software qualification and classification, June 2025 · Device Act Articles 54–56; MDCG section 3
Sources
- Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620
The inspected PDF is dated 19 November 2024. Advertising provisions were cross-checked against the current URPL advertising overview; recheck amendments before campaign sign-off.
- Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156
Public information must not have advertising characteristics. Information supplied at a patient's request under paragraph 2 is a different context.
- Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612
Consolidation reflects 8 April 2026. Later amendments exist; pharmacy advertising must also be read with the CJEU judgment and the October 2026 legislative tracker in the pharmacy framework. This is a targeted advertising review, not an audit of the entire Act.
- URPL — Advertising medical devices
- MDCG 2019-11 rev.1 — Software qualification and classification, June 2025
Non-binding MDCG guidance; the document expressly is not the Commission's official position.
- Medical-device advertising regulation — Dz.U. 2023 item 817
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- Patient Rights Act — consolidated text, Dz.U. 2024 item 581
Targeted review of these rights; not an audit of all subsequent amendments.
- Regulation (EU) 2016/679 — General Data Protection Regulation
A healthcare-processing basis does not automatically authorise advertising use.
- Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845
- UOKiK — Information about price reductions
- UOKiK — False reviews? Stop!
The 30 July 2024 announcement also describes enforcement decisions; their subsequent appeal status is not asserted here.
- Medicine advertising regulation — consolidated text, Dz.U. 2023 item 1648
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- Sejm official API — Pharmacy advertising amendment, process 3002
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in Poland
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Poland.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
Marketing & sales advisory
Casbeg
Marketing and sales consulting for businesses in Poland: strategy, commercial processes, lead generation and CRM implementation.
View partner profileBusiness & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.
